Finnish Authorities Order Google to Halt Construction on Massive AI Data Center Projects

Waymo, Alphabet's self-driving unit, secured a $5 billion term loan to expand its autonomous ride-hailing services. Lead lenders included PIMCO, Blackstone, and Sixth Street, with Goldman Sachs as the sole lead bookrunner. Waymo recently launched operations in its 15th US city and plans to expand to Singapore. Earlier this year, the company raised $16 billion in equity at a $126 billion valuation.

Securitize (SECZ) launched tokenized shares of Apple (AAPL), Microsoft (MSFT), Nvidia (NVDA), and others, backed 1:1 by actual shares. Tokens operate on Solana, settle in USDC, and offer shareholder rights. The company aims to bridge traditional markets with tokenization, with plans for round-the-clock trading.

Google signed a 20-year deal with Constellation Energy to buy 890 MW from upgraded nuclear reactors in Illinois, Pennsylvania, and New Jersey, investing $4.3B. This highlights a divide in firm power availability, favoring states with nuclear plants. Colorado, lacking nuclear capacity, faces challenges replacing coal with firm, carbon-free power. Uprates offer a quicker solution but are limited.

Meta and Alphabet are collaborating with the US government on a $1.8 billion AI biology initiative, with Meta contributing $300 million. The project aims to accelerate drug development using AI. Meta's stock has risen 18% in the last 6 months, with a price target of $798. Despite this initiative, Meta's core business and spending remain key drivers for its stock.

Alphabet (GOOGL) shares fell 0.7% to $342.15 on October 7. Wells Fargo raised its price target to $417, citing expected external TPU sales of $9.2B (Q3) and $11.5B (Q4). The bank noted Google's plans to sell AI chips to customers' data centers, potentially expanding its customer base. The stock is 34.87% above GF Value™ estimate of $253.69.

Biohub, Google, Meta, and the U.S. government are collaborating on a $1.8B project to generate biological data for AI models. Google, Meta, and Isomorphic Labs will invest $300M, while the DOE and NIH will contribute over $500M each. The goal is to create standardized data for predictive cell models, accelerating scientific research.